Fulcrum Therapeutics - Stock Price History | FULC

Historical daily share price chart and data for Fulcrum Therapeutics since 2021 adjusted for splits. The latest closing stock price for Fulcrum Therapeutics as of September 27, 2021 is 27.26.
  • The all-time high Fulcrum Therapeutics stock closing price was 30.97 on September 20, 2021.
  • The Fulcrum Therapeutics 52-week high stock price is 33.10, which is 21.4% above the current share price.
  • The Fulcrum Therapeutics 52-week low stock price is 6.85, which is 74.9% below the current share price.
  • The average Fulcrum Therapeutics stock price for the last 52 weeks is 13.01.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Fulcrum Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 13.7469 15.8600 22.0600 7.2200 11.7100 -29.63%
2019 10.2337 13.5000 18.1400 4.4600 16.6400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.099B $0.009B
Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29